Effects of an immunosuppressive treatment in the GRMD dog model of Duchenne muscular dystrophy.
The GRMD (Golden retriever muscular dystrophy) dog has been widely used in pre-clinical trials targeting DMD (Duchenne muscular dystrophy), using in many cases a concurrent immune-suppressive treatment. The aim of this study is to assess if such a treatment could have an effect on the disease course...
Main Authors: | Inès Barthélémy, Ane Uriarte, Carole Drougard, Yves Unterfinger, Jean-Laurent Thibaud, Stéphane Blot |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3504044?pdf=render |
Similar Items
-
Oxidative damage to urinary proteins from the GRMD dog and mdx mouse as biomarkers of dystropathology in Duchenne muscular dystrophy.
by: Jessica R Terrill, et al.
Published: (2020-01-01) -
Replenishing NAD+ content reduces aspects of striated muscle disease in a dog model of Duchenne muscular dystrophy
by: Déborah Cardoso, et al.
Published: (2023-12-01) -
Spatial and Temporal Non-Uniform Changes in Left Ventricular Myocardial Strain in Dogs with Duchenne Muscular Dystrophy
by: Bijan Ghaleh, et al.
Published: (2023-05-01) -
Levels of α7 integrin and laminin-α2 are increased following prednisone treatment in the mdx mouse and GRMD dog models of Duchenne muscular dystrophy
by: Ryan D. Wuebbles, et al.
Published: (2013-09-01) -
Gait characterization in golden retriever muscular dystrophy dogs using linear discriminant analysis
by: Bodvaël Fraysse, et al.
Published: (2017-04-01)